Increased exposure of phosphatidylethanolamine on the surface of tumor vascular endothelium

Neoplasia

Volumn 13, Issue 4, 2011, Pages 299-308

  Stafford, Jason H ^a   Thorpe, Philip E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LANCOVUTIDE; PHOSPHATIDYLETHANOLAMINE; REACTIVE OXYGEN METABOLITE;

ACIDITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL HYPOXIA; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; COW; DISEASE MARKER; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; IRRADIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

EID: 79953695111     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.101366     Document Type: Article

References (37)

1. Williamson P and Schlegel RA (1994). Back and forth: the regulation and function of transbilayer phospholipid movement in eukaryotic cells. Mol Membr Biol 11, 199-216.
2. Marconescu A and Thorpe PE (2008). Coincident exposure of phosphatidylethanolamine and anionic phospholipids on the surface of irradiated cells. Biochim Biophys Acta 1778, 2217-2224.
3. Devaux PF (1992). Protein involvement in transmembrane lipid asymmetry. Annu Rev Biophys Biomol Struct 21, 417-439.
4. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, and Henson PM (1992). Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148, 2207-2216.
5. Fadok VA, Bratton DL, and Henson PM (2001). Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J Clin Invest 108, 957-962.
6. Emoto K, Toyama-Sorimachi N, Karasuyama H, Inoue K, and Umeda M (1997). Exposure of phosphatidylethanolamine on the surface of apoptotic cells. Exp Cell Res 232, 430-434.
7. Bitbol M, Fellmann P, Zachowski A, and Devaux PF (1987). Ion regulation of phosphatidylserine and phosphatidylethanolamine outside-inside translocation in human erythrocytes. Biochim Biophys Acta 904, 268-282.
8. Zhou Q, Zhao J, Stout JG, Luhm RA, Wiedmer T, and Sims PJ (1997). Molecular cloning of human plasma membrane phospholipid scramblase. A protein mediating transbilayer movement of plasma membrane phospholipids. J Biol Chem 272, 18240-18244.
9. Mathias S, Pena LA, and Kolesnick RN (1998). Signal transduction of stress via ceramide. Biochem J 335(pt 3), 465-480.
10. Hannun YA, Luberto C, and Argraves KM (2001). Enzymes of sphingolipid metabolism: from modular to integrative signaling. Biochemistry 40, 4893-4903.
11. Taniguchi Y, Ohba T, Miyata H, and Ohki K (2006). Rapid phase change of lipid microdomains in giant vesicles induced by conversion of sphingomyelin to ceramide. Biochim Biophys Acta 1758, 145-153.
12. Kornberg RD and McConnell HM (1971). Inside-outside transitions of phospholipids in vesicle membranes. Biochemistry 10, 1111-1120.
13. Zulueta JJ, Yu FS, Hertig IA, Thannickal VJ, and Hassoun PM (1995). Release of hydrogen peroxide in response to hypoxia-reoxygenation: role of an NAD(P)H oxidase-like enzyme in endothelial cell plasma membrane. Am J Respir Cell Mol Biol 12, 41-49.
14. Ran S, Downes A, and Thorpe PE (2002). Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res 62, 6132-6140.
15. Ran S, He J, Huang X, Soares M, Scothorn D, and Thorpe PE (2005). Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice. Clin Cancer Res 11, 1551-1562.
16. Iwamoto K, Hayakawa T, Murate M, Makino A, Ito K, Fujisawa T, and Kobayashi T (2007). Curvature-dependent recognition of ethanolamine phospholipids by duramycin and cinnamycin. Biophysical Journal 93, 1608-1619.
17. Hayashi F, Nagashima K, Terui Y, Kawamura Y, Matsumoto K, and Itazaki H (1990). The structure of PA48009: the revised structure of duramycin. J Antibiot (Tokyo) 43, 1421-1430.
18. Zimmermann N, Freund S, Fredenhagen A, and Jung G (1993). Solution structures of the lantibiotics duramycin B and C. Eur J Biochem 216, 419-428.
19. 99mTc-labeled duramycin as a novel - phosphatidylethanolamine-binding molecular probe. J Nucl Med 49, 1345-1352.
20. Price JE (1996). Metastasis from human breast cancer cell lines. Breast Cancer Res Treat 39, 93-102.
21. Guy CT, Cardiff RD, and Muller WJ (1992). Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 12, 954-961. Neoplasia Vol. 13, No. 4, 2011 Phosphatidylethanolamine on Tumor Endothelium Stafford and Thorpe 307
22. Burrows FJ, Watanabe Y, and Thorpe PE (1992). A murine model for antibodydirected targeting of vascular endothelial cells in solid tumors. Cancer Res 52, 5954-5962.
23. Hagenbuch B (2010). Drug uptake systems in liver and kidney: a historic perspective. Clin Pharmacol Ther 87, 39-47.
24. vanMontfoort JE, Hagenbuch B, Groothuis GM, Koepsell H, Meier PJ, and Meijer DK(2003).Drug uptake systems in liver and kidney. Curr DrugMetab 4, 185-211.
25. Hockel M and Vaupel P (2001). Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93, 266-276.
26. Vaupel P, Mayer A, and Hockel M (2004). Tumor hypoxia and malignant progression. Methods Enzymol 381, 335-354.
27. Daleke DL (2003). Regulation of transbilayer plasma membrane phospholipids asymmetry. J Lipid Res 44, 233-242.
28. Emoto K, Kobayashi T, Yamaji A, Aizawa H, Yahara I, Inoue K, and Umeda M (1996). Redistribution of phosphatidylethanolamine at the cleavage furrow of dividing cells during cytokinesis. Proc Natl Acad Sci USA 93, 12867-12872.
29. Li Z, Wells CW, Esmon CT, and Zhao M (2009). Phosphatidylethanolamine at the endothelial surface of aortic flow dividers. J Thromb Haemost 7, 227-229.
30. Szatrowski TP and Nathan CF (1991). Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51, 794-798.
31. Fantone JC and Ward PA (1982). Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 107, 395-418.
32. Storz P (2005). Reactive oxygen species in tumor progression. Front Biosci 10, 1881-1896.
33. Lopez-Lazaro M (2008). The Warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen? Anticancer Agents Med Chem 8, 305-312.
34. Zachowski A, Favre E, Cribier S, Herve P, and Devaux PF (1986). Outsideinside translocation of aminophospholipids in the human erythrocyte membrane is mediated by a specific enzyme. Biochemistry 25, 2585-2590.
35. Sheth TR, Henderson RM, Hladky SB, and Cuthbert AW (1992). Ion channel formation by duramycin. Biochim Biophys Acta 1107, 179-185.
36. Sokolove PM, Westphal PA, Kester MB, Wierwille R, and Sikora-VanMeter K (1989). Duramycin effects on the structure and function of heart mitochondria. I. Structural alterations and changes in membrane permeability. Biochim Biophys Acta 983, 15-22.
37. Makino A, Baba T, Fujimoto K, Iwamoto K, Yano Y, Terada N, Ohno S, Sato SB, Ohta A, Umeda M, et al. (2003). Cinnamycin (Ro 09-0198) promotes cell binding and toxicity by inducing transbilayer lipid movement. J Biol Chem 278, 3204-3209